Navigation Links
Breakthrough HIV Technology Could Revolutionize Patient Care in Zimbabwe
Date:2/9/2013

Waltham, Massachusetts (PRWEB) February 09, 2013

Alere Inc. is pleased to announce that, with the aid of a revolutionary point-of-care device, World Health Clinicians, a US-based nongovernmental organization, were able to provide absolute CD4 counts for patients living with HIV in rural Zimbabwe in under 20 minutes. This outcome is the result of a proof-of-concept evaluation World Health Clinicians performed in conjunction with the Zimbabwean Ministry of Health. Zimbabwe has a population of approximately 11.6 million people, 1.2 million of whom are infected with HIV.

In HIV-infected individuals, total CD4 count is the most robust surrogate marker for immune competence, identifying when patients need to start life-saving, antiretroviral therapy. As part of its evaluation, the World Health Clinicians team ran rapid HIV screening tests as well as total CD4 cell counts, providing a complete set of results in less than one hour, a service that is currently unavailable in even the most developed parts of the world. More information about the evaluation and its results can be found by accessing the link below.

VIDEO    http://alerehiv.com/video/alere-pima-cd4-in-zimbabwe/

Designed and engineered in Germany, the Alere Pima™ CD4 test provides an accurate, absolute CD4 count using a small amount of blood drawn from a fingerstick. The analyzer weighs 2.5kg (5.5lbs) and runs on either battery or A/C power, allowing for easy transport and use in even the most remote and challenging environments.

In particular, the Alere Pima™ CD4 test enabled the team from World Health Clinicians to conduct house-to-house CD4 testing outside the clinic, reaching patients who would otherwise go without results. Moreover, when the clinic lost power for 3 ½ hours, a common occurrence in the region, the team was able to switch to battery-operated power and continue CD4 testing.

“I think this is one of the most practical systems I’ve ever seen–for the fact that it’s so lightweight, it lasts so long with the back-up battery, and it takes twenty minutes and a single fingerstick to run,” said Dr Gary Blick, CEO of World Health Clinicians. “I would love to have access to this in the United States.”

Alere, a leading provider of near-patient diagnostics, is committed to developing solutions that support the screening and monitoring of people living with HIV. The company manufactures a range of point-of-care diagnostics for HIV screening, monitoring and the detection of such co-morbidities as tuberculosis, including the Alere Determine™ HIV-1/2 and the Alere Determine™ TB LAM Ag tests.

For more information about Alere’s diagnostic tools for chronic HIV management, go to http://www.AlereHIV.com.

About Alere
By developing new capabilities in near-patient diagnosis, monitoring and health information technology, Alere enables individuals to take charge of improving their health and quality of life at home. Alere's global leading products and services, as well as its new product development efforts, focus on cardiology, infectious disease, toxicology and diabetes. Alere is headquartered in Waltham, Massachusetts. For more information regarding Alere, please visit http://www.alere.com.

Read the full story at http://www.prweb.com/releases/2013/2/prweb10411079.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Bascom Palmer Eye Institute announces breakthrough for degenerative vision disorder
2. Scientists make breakthrough in bile duct cancer with discovery of new gene mutations
3. An important breakthrough in immunology by IRCM researchers
4. Ear, Nose & Throat Journal publishes research on breakthrough treatment for tonsil stones
5. Trivedi Beef, LLC Announces Breakthrough Beef Industry Data without the use of Antibiotic Drugs, Hormones or Steroids
6. Breakthrough Brings Transparency to Male/Female Relationships
7. Breakthrough treatment reduces post-surgical scarring for glaucoma patients
8. Research breakthrough could halt melanoma metastasis
9. Breakthrough nanoparticle halts multiple sclerosis
10. Nanomedicine breakthrough could improve chemotherapy for childhood cancer
11. Western University researchers make breakthrough in arthritis research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... (PRWEB) , ... March 27, 2017 , ... ... the GTEC Orange facility from 8:00am-10:00am on Monday, April 3rd to commemorate the ... will be an opportunity for area-residents to celebrate two great years while also ...
(Date:3/27/2017)... ... March 27, 2017 , ... The homeowner improvement and repair market ... utilizing DIY and unlicensed contractors for renovations is also on the rise. Per a ... 2015, and of those, 42% failed to use a licensed contractor.(2) The risks associated ...
(Date:3/26/2017)... ... March 26, 2017 , ... Local physician ... 100 Award, a prestigious award honoring the top influencers on RealSelf—the most trusted ... connect with doctors and clinics. , In 2016, more than 82 million people ...
(Date:3/25/2017)... ... March 25, 2017 , ... Norland at Swissray is pleased to announce ... large subjects. The ELITE DXA has an active scan window, which is more than ... to fit in the scan area could not undergo an accurate total body bone density ...
(Date:3/24/2017)... ... March 24, 2017 , ... Vighter established its ... time by providing Prehospital Trauma Life Support (PHTLS) course scholarships to four medics ... trauma education developed in cooperation with the American College of Surgeons to promote ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... HAYWARD, Calif. , March 27, 2017  Impax ... Directors has appointed Paul M. Bisaro as ... of the Company,s Board, effective March 27, 2017. Mr. ... has served as Interim President and Chief Executive Officer ... years of generic and branded pharmaceutical experience, Mr. Bisaro, ...
(Date:3/27/2017)... March 27, 2017  PhaseRx, Inc. (NASDAQ: PZRX), ... inherited liver diseases in children, today reported financial ... ended December 31, 2016 and provided an update ... continued to make progress during the fourth quarter ... from our non-human primate safety study, and with our ...
(Date:3/27/2017)... Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ) ... across multiple therapeutic areas, today announced that Amit Munshi , ... corporate update at the 16th Annual Needham Healthcare Conference on ... place April 4-5, 2017 at the Westin New York Grand ... A live audio webcast of the presentation will ...
Breaking Medicine Technology: